We are live on ! Find out more
EAM

Eventide Asset Management Portfolio holdings

AUM $6.05B
1-Year Est. Return 76.64%
This Fund
S&P 500
This Quarter Est. Return
+9.63%
1 Year Est. Return
+76.64%
3 Year Est. Return
+247.17%
5 Year Est. Return
+285.6%
10 Year Est. Return
+2,546.71%
AUM
$1.33B
AUM Growth
+$413M
Cap. Flow
+$332M
Cap. Flow %
24.95%
Top 10 Hldgs %
26.03%
Holding
123
New
17
Increased
53
Reduced
6
Closed
12

Top Buys

Rank Stock Value
1
LRCX icon
Lam Research
LRCX
+$27.7M
2
SNDK
SANDISK CORP
SNDK
+$26.1M
3
STLD icon
Steel Dynamics
STLD
+$19.7M
4
XPO icon
XPO
XPO
+$19.4M
5
MBLY
Mobileye N.V.
MBLY
+$19.2M

Top Sells

Rank Stock Value
1
TRW
TRW AUTOMOTIVE HOLDINGS CORP
TRW
+$20.4M
2
LYB icon
LyondellBasell Industries
LYB
+$10.6M
3
AGIO icon
Agios Pharmaceuticals
AGIO
+$10.3M
4
PCYC
PHARMACYCLICS INC
PCYC
+$10.1M
5
MEOH icon
Methanex
MEOH
+$9.23M

Sector Composition

Rank Sector Weight
1 Healthcare 25.62%
2 Technology 20.76%
3 Consumer Discretionary 14.72%
4 Industrials 11.01%
5 Energy 4.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SCTY
51
DELISTED
SolarCity Corporation
SCTY
$9.69M 0.73%
189,000
+100,000
+112% +$5.14M
TEX icon
52
Terex
TEX
$7.11B
$9.37M 0.7%
352,200
+48,700
+16% +$1.23M
ININ
53
DELISTED
Interactive Intelligence Group, inc.
ININ
$9.15M 0.69%
222,200
– –
AYR
54
DELISTED
Aircastle Ltd
AYR
$8.97M 0.68%
399,600
– –
STML
55
DELISTED
Stemline Therapeutics, Inc.
STML
$8.97M 0.68%
620,200
+19,700
+3% +$302K
CGNX icon
56
Cognex
CGNX
$10.4B
$8.93M 0.67%
360,000
– –
ACAD icon
57
Acadia Pharmaceuticals
ACAD
$4.55B
$8.84M 0.66%
271,100
-152,100
-36% -$5.23M
LGND icon
58
Ligand Pharmaceuticals
LGND
$5.94B
$8.75M 0.66%
181,941
-58,028
-24% -$2.22M
ZSAN
59
DELISTED
Zosano Pharma Corporation
ZSAN
$8.38M 0.63%
+1,184
New +$8.88M
CLDX icon
60
Celldex Therapeutics
CLDX
$3.02B
$8.05M 0.61%
19,247
– –
VMW
61
DELISTED
VMware, Inc
VMW
$8.02M 0.6%
97,800
– –
SGMO
62
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$7.57M 0.57%
482,500
– –
OII icon
63
Oceaneering
OII
$4.74B
$7M 0.53%
129,700
– –
PWR icon
64
Quanta Services
PWR
$98.7B
$6.64M 0.5%
232,800
+50,000
+27% +$1.4M
CMRE icon
65
Costamare
CMRE
$1.87B
$6.34M 0.48%
360,200
– –
NBIX icon
66
Neurocrine Biosciences
NBIX
$18.7B
$5.47M 0.41%
137,800
+25,600
+23% +$916K
CEMP
67
DELISTED
Cempra, Inc.
CEMP
$5.28M 0.4%
153,800
– –
TSRO
68
DELISTED
TESARO, Inc.
TSRO
$5.03M 0.38%
87,700
+12,700
+17% +$598K
BMRN icon
69
BioMarin Pharmaceuticals
BMRN
$11.7B
$5M 0.38%
40,100
+9,900
+33% +$1.05M
CERN
70
DELISTED
Cerner Corp
CERN
$4.4M 0.33%
60,100
+21,200
+54% +$1.47M
ALNY icon
71
Alnylam Pharmaceuticals
ALNY
$27.4B
$4.38M 0.33%
+41,900
New +$4.25M
FC icon
72
Franklin Covey
FC
$243M
$4.33M 0.33%
224,964
-90,636
-29% -$1.63M
RARE icon
73
Ultragenyx Pharmaceutical
RARE
$2.56B
$4.28M 0.32%
69,000
+16,400
+31% +$911K
AGTC
74
DELISTED
Applied Genetic Technologies Corporation
AGTC
$4.11M 0.31%
205,500
– –
XNCR icon
75
Xencor
XNCR
$1.59B
$3.95M 0.3%
+258,100
New +$4.07M
1 2
3
4 5

Similar funds

HPG
Harvest Portfolios Group Oakville, Ontario, Canada $6.06B AUM 16.63% 1-Year Est. Return
EMPI
Elo Mutual Pension Insurance Espoo, Finland $6.06B AUM 24.33% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
JWBC
John W. Bristol & Co New York $6.08B AUM 16.51% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
CM
CastleKnight Management New York $6B AUM 121.87% 1-Year Est. Return
CIS
Capital International Sarl Los Angeles, California $6.11B AUM 32.29% 1-Year Est. Return

Eventide Asset Management's Q1 2015 Portfolio in Review

As of Q1 2015, Eventide Asset Management held 123 positions worth $1.33B, up 45% from $916M the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Eventide Asset Management deployed $332M of net new capital in Q1 2015, opening 17 new positions and adding to 53 existing holdings. Its largest new stake was Lam Research: 3,509,000 shares worth $24.6M.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, down from 31% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Agios Pharmaceuticals, an estimated $10.3M trimmed.

  • Eventide Asset Management's largest Q1 2015 buy was Lam Research: 3,509,000 shares worth $24.6M.
  • Eventide Asset Management added most to XPO in Q1 2015, an estimated $19.4M increase.
  • Eventide Asset Management's biggest Q1 2015 reduction was Agios Pharmaceuticals, cutting an estimated $10.3M.
  • Eventide Asset Management fully exited TRW AUTOMOTIVE HOLDINGS CORP in Q1 2015, selling an estimated $20.4M.
  • Eventide Asset Management's ten largest holdings make up 26% of its $1.33B portfolio in Q1 2015.
  • Eventide Asset Management opened 17 new positions and closed 12 in Q1 2015.
  • Eventide Asset Management's portfolio value rose 45% quarter-over-quarter to $1.33B.

Based on Eventide Asset Management's 13F filing for Q1 2015, filed 14 May 2015.